Corteva (NYSE:CTVA) Price Target Raised to $89.00

Corteva (NYSE:CTVA) had its price objective hoisted by UBS Group from $86.00 to $89.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

CTVA has been the topic of several other reports. BNP Paribas Exane lifted their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Citigroup raised their target price on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research note on Monday. Mizuho lifted their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Morgan Stanley boosted their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Finally, Rothschild & Co Redburn upped their price target on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $91.38.

Corteva Stock Up 0.7%

CTVA stock opened at $78.82 on Monday. Corteva has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a market capitalization of $52.59 billion, a price-to-earnings ratio of 52.20, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The firm’s 50-day moving average is $82.03 and its two-hundred day moving average is $79.79. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the firm posted $2.20 earnings per share. The business’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts forecast that Corteva will post 3.74 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Institutional Investors Weigh In On Corteva

Hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in Corteva by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after acquiring an additional 317,538 shares during the period. State Street Corp grew its position in Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after purchasing an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. grew its position in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after purchasing an additional 805,873 shares in the last quarter. Harris Associates L P increased its stake in Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Finally, Northern Trust Corp lifted its position in Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after buying an additional 562,550 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.